Fingerprint
Dive into the research topics of 'Lenalidomide and prednisone for myelofibrosis: Eastern Cooperative Oncology Group (ECOG) phase 2 trial E4903'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Lenalidomide and prednisone for myelofibrosis: Eastern Cooperative Oncology Group (ECOG) phase 2 trial E4903
Ruben A. Mesa, Xiaopan Yao, Larry D. Cripe, Chin Yang Li, Mark Litzow, Elisabeth Paietta, Jacob M. Rowe, Ayalew Tefferi, Martin S. Tallman
Research output: Contribution to journal › Article › peer-review
111
Scopus
citations